Containing the same active ingredient as Wegovy (semaglutide), Ozempic is approved to manage type 2 diabetes and related health conditions, such as heart or kidney disease , in people with type 2 diabetes
Their study demonstrated that acute pro-inflammatory changes were already observed 24 hours after the stimulus, whereas anti-inflammatory genes, including IL-10, peaked between 4 and 6 hours
February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026
Shi, W., Chen, Z., Chen, X., Cao, L., Liu, P., & Sun, S
Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species